Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HDW6
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 11 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009056 | catabolic process | 2 | 11 |
GO:0009057 | macromolecule catabolic process | 4 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044248 | cellular catabolic process | 3 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 11 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
GO:1901575 | organic substance catabolic process | 3 | 11 |
GO:0016579 | protein deubiquitination | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0070646 | protein modification by small protein removal | 5 | 1 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004843 | cysteine-type deubiquitinase activity | 5 | 11 |
GO:0008233 | peptidase activity | 3 | 11 |
GO:0008234 | cysteine-type peptidase activity | 4 | 11 |
GO:0016787 | hydrolase activity | 2 | 11 |
GO:0019783 | ubiquitin-like protein peptidase activity | 4 | 11 |
GO:0101005 | deubiquitinase activity | 5 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 117 | 121 | PF00656 | 0.391 |
CLV_C14_Caspase3-7 | 197 | 201 | PF00656 | 0.421 |
CLV_NRD_NRD_1 | 187 | 189 | PF00675 | 0.316 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.219 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.176 |
CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.388 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.388 |
CLV_PCSK_PC1ET2_1 | 144 | 146 | PF00082 | 0.176 |
CLV_PCSK_PC1ET2_1 | 61 | 63 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 215 | 219 | PF00082 | 0.231 |
CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.433 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.388 |
DOC_MAPK_gen_1 | 78 | 85 | PF00069 | 0.176 |
DOC_PP1_RVXF_1 | 23 | 29 | PF00149 | 0.275 |
DOC_PP1_RVXF_1 | 80 | 86 | PF00149 | 0.176 |
DOC_USP7_MATH_1 | 4 | 8 | PF00917 | 0.291 |
DOC_USP7_UBL2_3 | 134 | 138 | PF12436 | 0.260 |
DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.382 |
LIG_14-3-3_CanoR_1 | 14 | 21 | PF00244 | 0.333 |
LIG_14-3-3_CanoR_1 | 82 | 91 | PF00244 | 0.234 |
LIG_CSL_BTD_1 | 1 | 4 | PF09270 | 0.336 |
LIG_EH1_1 | 224 | 232 | PF00400 | 0.495 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.181 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.540 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.220 |
LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.257 |
LIG_SH3_3 | 39 | 45 | PF00018 | 0.259 |
LIG_SUMO_SIM_anti_2 | 96 | 101 | PF11976 | 0.271 |
LIG_TRAF2_1 | 153 | 156 | PF00917 | 0.336 |
LIG_TRAF2_1 | 211 | 214 | PF00917 | 0.380 |
MOD_Cter_Amidation | 186 | 189 | PF01082 | 0.313 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.333 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.415 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.250 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.193 |
MOD_N-GLC_1 | 200 | 205 | PF02516 | 0.333 |
MOD_N-GLC_2 | 92 | 94 | PF02516 | 0.257 |
MOD_NEK2_1 | 225 | 230 | PF00069 | 0.539 |
MOD_PIKK_1 | 83 | 89 | PF00454 | 0.176 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.176 |
MOD_Plk_1 | 199 | 205 | PF00069 | 0.337 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.344 |
MOD_Plk_4 | 200 | 206 | PF00069 | 0.272 |
MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.382 |
MOD_SUMO_rev_2 | 128 | 136 | PF00179 | 0.200 |
MOD_SUMO_rev_2 | 17 | 26 | PF00179 | 0.435 |
TRG_DiLeu_BaEn_4 | 72 | 78 | PF01217 | 0.260 |
TRG_ER_diArg_1 | 77 | 79 | PF00400 | 0.308 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0E1 | Leptomonas seymouri | 65% | 99% |
A0A0N1I1H5 | Leptomonas seymouri | 28% | 76% |
A0A0S4J7R4 | Bodo saltans | 22% | 75% |
A0A0S4JHD6 | Bodo saltans | 47% | 99% |
A0A1X0P4J5 | Trypanosomatidae | 42% | 99% |
A0A3Q8IGE5 | Leishmania donovani | 77% | 100% |
A0A3S7WY30 | Leishmania donovani | 26% | 76% |
A4HD98 | Leishmania braziliensis | 25% | 100% |
A4I161 | Leishmania infantum | 78% | 100% |
D0A5E6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 99% |
D0A712 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 75% |
E9AH53 | Leishmania infantum | 26% | 76% |
E9AWN2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 76% |
E9AX95 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
O01391 | Aplysia californica | 35% | 100% |
P09936 | Homo sapiens | 34% | 100% |
P15374 | Homo sapiens | 36% | 100% |
P23356 | Bos taurus | 29% | 92% |
P35122 | Drosophila melanogaster | 36% | 100% |
P35127 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 99% |
P50103 | Monodelphis domestica | 35% | 100% |
P58321 | Mus musculus | 34% | 100% |
Q00981 | Rattus norvegicus | 33% | 100% |
Q06AB3 | Sus scrofa | 36% | 100% |
Q06AT3 | Sus scrofa | 24% | 71% |
Q09444 | Caenorhabditis elegans | 23% | 73% |
Q10171 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 29% | 100% |
Q2TBG8 | Bos taurus | 36% | 100% |
Q4QA77 | Leishmania major | 78% | 100% |
Q4QAT9 | Leishmania major | 26% | 100% |
Q54N38 | Dictyostelium discoideum | 24% | 68% |
Q54T48 | Dictyostelium discoideum | 31% | 91% |
Q60HC8 | Macaca fascicularis | 34% | 100% |
Q6SEG5 | Sus scrofa | 33% | 100% |
Q8GWE1 | Arabidopsis thaliana | 38% | 100% |
Q8IKM8 | Plasmodium falciparum (isolate 3D7) | 34% | 100% |
Q91Y78 | Rattus norvegicus | 36% | 100% |
Q9FFF2 | Arabidopsis thaliana | 24% | 70% |
Q9GM50 | Equus caballus | 33% | 100% |
Q9JKB1 | Mus musculus | 36% | 100% |
Q9R0P9 | Mus musculus | 33% | 100% |
Q9UUB6 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 22% | 78% |
Q9WUP7 | Mus musculus | 23% | 71% |
Q9XSJ0 | Bos taurus | 24% | 71% |
Q9Y5K5 | Homo sapiens | 24% | 71% |
V5BN93 | Trypanosoma cruzi | 44% | 99% |